Markers of endothelial dysfunction and insulin resistance. beneficial effects of rosiglitazone in type 2 diabetes

被引：0
|
作者：
Albertini, JP
Chen, HZ
Mather, R
Valensi, P
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A117 / A117
页数：1
相关论文
共 50 条
  • [1] Markers of endothelial dysfunction and insulin resistance. Beneficial effects of rosiglitazone in type 2 diabetes
    Albertini, JP
    Chen, H
    Mather, RA
    Valensi, P
    EUROPEAN HEART JOURNAL, 2004, 25 : 455 - 455
  • [2] Endothelial dysfunction and insulin resistance. Beneficial effects of rosiglitazone on type 2 diabetes
    Albertini, JP
    Chen, HZ
    Mather, R
    Valensi, PE
    CIRCULATION, 2004, 110 (17) : 811 - 812
  • [3] Beneficial effects of rosiglitazone on insulin resistance and endothelial dysfunction in patients with type 2 diabetes
    Albertini, JP
    Chen, H
    Mather, R
    Valensi, PE
    DIABETOLOGIA, 2004, 47 : A29 - A29
  • [4] Endothelial dysfunction in insulin resistance and type 2 diabetes
    Jansson, P.-A.
    JOURNAL OF INTERNAL MEDICINE, 2007, 262 (02) : 173 - 183
  • [5] In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control
    Pistrosch, F
    Passauer, J
    Fischer, S
    Fuecker, K
    Hanefeld, M
    Gross, P
    DIABETES CARE, 2004, 27 (02) : 484 - 490
  • [6] Beneficial effects of nateglinide on insulin resistance in type 2 diabetes
    Hazama, Y
    Matsuhisa, M
    Ohtoshi, K
    Gorogawa, S
    Kato, K
    Kawamori, D
    Yoshiuchi, K
    Nakamura, Y
    Shiraiwa, T
    Kaneto, H
    Yamasaki, Y
    Hori, M
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2006, 71 (03) : 251 - 255
  • [7] Association between insulin resistance and endothelial dysfunction in type 2 diabetes and the effects of pioglitazone
    Suzuki, Masaaki
    Takamisawa, Itaru
    Yoshimasa, Yasunao
    Harano, Yutaka
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (01) : 12 - 17
  • [8] The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus
    Evren Fidan
    H. Onder Ersoz
    Mustafa Yilmaz
    Hulya Yilmaz
    Mustafa Kocak
    Caner Karahan
    Cihangir Erem
    Acta Diabetologica, 2011, 48 : 297 - 302
  • [9] The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus
    Fidan, Evren
    Ersoz, H. Onder
    Yilmaz, Mustafa
    Yilmaz, Hulya
    Kocak, Mustafa
    Karahan, Caner
    Erem, Cihangir
    ACTA DIABETOLOGICA, 2011, 48 (04) : 297 - 302
  • [10] Metformin reverses endothelial dysfunction associated with insulin resistance.
    Miller, AW
    Katakam, PVG
    Ujhelyi, MR
    FASEB JOURNAL, 1999, 13 (05): : A834 - A834
12345